GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
25 hedge funds and large institutions have $5.23M invested in Amplify Treatments, Testing and Advancements ETF in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+5
Holders Change %
+25%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
9
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
LPL Financial
San Diego,
California
|
+$838K |
| 2 |
G
Gainplan
Bloomfield Hills,
Michigan
|
+$298K |
| 3 |
APA
American Portfolios Advisors
Holbrook,
New York
|
+$297K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$289K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$185K |
